Introducing the Future of Eye Care: A Message from Dr. Garth Webb
Welcome to the forefront of innovation in eye care! I am Dr. Garth Webb, the founder, Chief Scientific Officer, and Board Chair of Ocumetics Technology Corporation, a publicly traded company (TSXV: OTC). Additionally, I am the proprietor of VENTURA Health Sciences Corporation (Ventura), a privately held Canadian company.
About Ocumetics Technology Corporation
Ocumetics is a pioneering research and development (R&D) company dedicated to revolutionizing eye care. Through years of rigorous research, we have achieved groundbreaking advancements in accommodating intraocular lens (AIOL) technologies. Our inaugural AIOL is currently undergoing Phase 1 clinical trials and is scheduled for Proof-of-Concept human trials in the third quarter of 2024. This lens represents a historic milestone in contemporary ophthalmology, offering unparalleled safety and efficacy. It marks the beginning of a new era of intraocular therapies and optical systems, paving the way for advanced human enhancement technologies.
About VENTURA Health Sciences Corporation
VENTURA specializes in functional dietary supplements, particularly for eye care. Our primary objective is to combat age-related macular degeneration and prepare a platform for excellence in dietary/lifestyle counseling services relevant to eye care.
The Celebration of Sight Initiative
As a major shareholder in Ocumetics, I have dedicated up to 80% of VENTURA's equity earnings from Ocumetics to fund the Celebration of Sight Initiative. This initiative supports three equally important mandates, including the 2020+ Campaign.
The 2020+ Campaign
The 2020+ Campaign is exclusively designed to fortify the value position of Canadian eye doctors and their patients. It empowers eye care professionals to become architects of eye care, safeguarding the fiduciary interests and wellbeing of their patients.
Benefits for Eye Recommend Members
Eye Recommend doctors have the opportunity to participate in the 2020+ Campaign, gaining access to exclusive benefits and resources. Early adopters can benefit from special financial provisions aimed at combating the needless loss of eyesight due to macular degeneration.
How to Get Involved
Eye Recommend members and select Canadian ophthalmologists can register for the 2020+ Campaign or request more information by emailing us at 2020plus@venturahealth.ca. Join us in shaping the future of eye care and ensuring a brighter vision for all!
Stay tuned for updates and further details as we embark on this exciting journey together.
Note: Certain terms and conditions apply. Offer is subject to availability and on a first-come, first-served basis.